LDHA and gastric cancer: MiR‐34a re-sensitizes colon cancer cells to 5-FU (142), miR-329-3p sensitizes osteosarcoma cells to cisplatin (143), and miR-7 sensitizes gastric cancer cells to cisplatin (144) all via LDHA inhibition.